Political pundit Karl Rove to speak at CRN conference
WASHINGTON — The Council for Responsible Nutrition earlier this week announced that political pundit and former White House senior adviser Karl Rove will be a featured speaker at The Conference, CRN’s annual symposium for the dietary supplement industry.
Speaking on the final day of The Conference, Rove will provide his thoughts on the current political climate and share his insight into the inner workings of Congress, the White House and the political process. He also will share some personal recollections from his nearly eight years as a close adviser to President George W. Bush and from his extensive career in American politics.
“Karl Rove is one of the premiere political strategists of the last half-century," stated John Venardos, chair of The Conference and SVP worldwide regulatory, government and industry affairs for Herbalife. "[Rove] has had a front-row seat to many important moments in American history and was actively involved in several of the most hotly contested political campaigns of the last 30 years. His time spent in the White House as deputy chief of staff and senior adviser to President Bush makes him a living witness to history, and his speech will surely be one of the highlights of The Conference.”
The Conference takes place Oct. 19 to 22 at the Terranea Resort in Rancho Palos Verdes, Calif.
Amylin, Takeda discontinue development of obesity drug
SAN DIEGO — Amylin Pharmaceuticals and Takeda Pharmaceutical have halted development of a treatment for obesity in mid-stage clinical trials, the two companies said.
The companies said the decision to discontinue development of a therapy that combines pramlintide and metreleptin was based on "a commercial reassessment of the pramlintide/metreleptin program … [that] took into account a revised development plan, as well as evolving dynamics within he obesity therapeutic area."
Nevertheless, the companies said they would continue investigating other treatments for obesity.
NACDS praises introduction of legislation to curb organized theft of medical products
ALEXANDRIA, Va. — A bipartisan bill that aims to provide law enforcement with tools to crack crime rings that harm consumers by attempting to resell stolen medical products on the black market has received the praise of the National Association of Chain Drug Stores.
In a letter sent to Sen. Charles E. Schumer, D-N.Y., NACDS thanked him for his leadership in introducing and advancing S. 1002, the “Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2011,” also called the “SAFE DOSES Act.”
The letter cites the importance of the bill in the fight against the organized theft of medical products, specifically prescription drugs, biologicals, devices and infant formula.
“Your timely legislation comes amid concerns that criminal organizations are increasingly targeting prescription drugs and other medical products, and particularly goods in transit, because of the high value of shipments. It would combat this type of theft by increasing penalties, stiffening sentences for these crimes, making theft of medical products a predicate for the Racketeer Influenced and Corrupt Organizations law, as well as providing law enforcement officials with additional mechanisms to fight dangerous crime rings,” NACDS stated in its letter.
“We commend you again for introducing and advancing strong bipartisan legislation that will assist healthcare providers, retailers and law enforcement combat the serious problem of organized theft of medical products and we look forward to working with you to enact this important legislation,” the letter concluded.